Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Inovio Pharmaceuticals
Sort By
Newest First
1 / 1
Clinical Trials
INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
Inovio Pharmaceuticals, Inc.
PR-10-24-NI-53
Oct 21, 2024
COVID-19
INOVIO Announces Positive Interim Phase 1 Data For INO-4800 Vaccine for COVID-19
Nice Insight
PR-M06-20-NI-039
Jun 30, 2020
COVID-19
INOVIO Receives $71 Million Contract from U.S. Department of Defense to Scale Up Manufacture of COVID-19 DNA Vaccine Delivery Device
Inovio Pharmaceuticals, Inc.
PR-M06-20-NI-030
Jun 23, 2020
Vaccine
Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial
Inovio Pharmaceuticals, Inc.
PR-M05-19-NI-074
May 28, 2019
Phase III
Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100
Inovio Pharmaceuticals, Inc.
PR-M05-19-NI-022
May 08, 2019
Immunotherapy
Deal with Inovio Launches ApolloBio’s Commercialization Plans in China
Guy Tiene
Nice Insight
PAO-M01-18-NI-009
Jan 05, 2018
Clinical Trials
HIV Vaccine Demonstrates “Remarkable” Rates
Emilie Branch
Pharma's Almanac
PAO-M05-17-NI-039
May 31, 2017
1 / 1
